PATENT CLAIM ANALYSIS

Application Number: 16268344
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["424", "185100"]

Abstract:
The invention relates to producing humoral response to P2X7 receptors in individuals having cancer, and to minimising the progression of cancer in said individuals.

Claim (Index 18):
The process according to  claim 17 , wherein the cancer in the individual has been reduced in size, mass or other physical measure prior to administration of the P2X 7  receptor or fragment thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.2381
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15399337', '14129240', '15085929', '13002647', '15910987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7457939869122264
- 35 USC 102 Novelty (BERT): 0.5605868405751617
- Combined Prediction Score: 0.7272732722785199
- Mean Citation Score: 365.366668
- Max Citation Score: 482.1742
- Similarity Product: 309.6593954050064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test